# EDGAR Filing Document

**Accession Number:** 0001622244
**File Stem:** 0001641172-25-016261
**Filing Date:** 2025-6
**Character Count:** 6610
**Document Hash:** 25b069f8c49561abc9582e7dd9a0f272
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001641172-25-016261.hdr.sgml**: 20250624

**ACCESSION NUMBER**: 0001641172-25-016261

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20241108

**FILED AS OF DATE**: 20250624

**DATE AS OF CHANGE**: 20250624

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Thomas Isiah III
- **CENTRAL INDEX KEY:** 0001807331

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-56151
- **FILM NUMBER:** 251067648

**MAIL ADDRESS:**
- **STREET 1:** TWO PENNSYLVANIA PLAZA
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10121
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** One World Products, Inc.
- **CENTRAL INDEX KEY:** 0001622244
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 611744826
- **STATE OF INCORPORATION:** NV
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 6605 GRAND MONTECITO PKWY
- **STREET 2:** SUITE 100
- **CITY:** LAS VEGAS
- **STATE:** NV
- **ZIP:** 89149
- **BUSINESS PHONE:** 7026050605

**MAIL ADDRESS:**
- **STREET 1:** 6605 GRAND MONTECITO PKWY
- **STREET 2:** SUITE 100
- **CITY:** LAS VEGAS
- **STATE:** NV
- **ZIP:** 89149

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** One World Pharma, Inc.
- **DATE OF NAME CHANGE:** 20190125

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** PUNTO GROUP, CORP.
- **DATE OF NAME CHANGE:** 20141014

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Thomas Isiah III<br><sub>(Last) (First) (Middle)</sub><br>6605 GRAND MONTECITO PKWY., SUITE 100<br><sub>(Street)</sub><br>LAS VEGAS, NV 89149<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2024-11-08 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[X] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_CEO and Chairman_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>One World Products, Inc. [ OWPC ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Series C Special Preferred Stock | 2024-11-08 |  | A |  | 100 | A | 486512<sup>(1)</sup> | 100<sup>(2)(3)</sup> | D |  |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |

---

### Footnotes:

(1) Shares of common stock were issued to Mr. Thomas for his service as Chief Executive Officer of the Issuer, in settlement of accrued compensation in the amount of $486,512.

(2) Beneficial ownership excludes 2,638,000 shares of common stock owned, and 200,000 shares of series B preferred stock, which is convertible into 20,000,000 shares of common stock.

(3) The Series C Special Preferred Stock, as a class, has rights in all matters requiring shareholder approval to a number of votes equal to two (2) times the sum of, a) the total number of shares of common stock which are issued and outstanding at the time of any election or vote by the shareholders; plus, b) the number of votes allocated to shares of Preferred Stock issued and outstanding of any other class that shall have voting rights.

**Signature:** /s/ Isiah L. Thomas, III  
**Date:** 2025-06-24

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**